Siblings Conference Papers/Meeting Abstract [23/37] Patents [0/18] Collection Statistics Item counts issued in 3 years:19(12.10%) Items With Fulltext:157(100.00%) Download counts of the item Download times greater than 0:157(100.00%) Download times greater than 100:153(97.45%) Total Bitstream Download Counts:84927(86.94%) Last Update: 2024-12-01 13:22 Top Upload Loading... Top Download Loading... Recent Submissions DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... Discovery of a long half-life AURKA... Postfermented tea extract potently ... Natural fucoidans inhibit coronavir... Development of furanopyrimidine-bas... The synergistic inhibition of coron... Omicron-specific mRNA vaccine induc... BPR0C261, an analogous of microtubu... Protective effect of CXCR4 antagoni...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 76-100 of 157. (7 Page(s) Totally) << < 1 2 3 4 5 6 7 > >> View [10|25|50] records per page

Date	Title	Relation
2014-01-08	Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer	PLoS ONE. 2014 Jan 8;9(1):Article number e83160.
2013-11	BPR0C305, an orally active microtubule-disrupting anticancer agent	Anticancer Drugs. 2013 Nov;24(10):1047-1057.
2013-10	Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats	Journal of Controlled Release. 2013 Oct;172(2):513-522.
2013-10	Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT	Biomaterials. 2013 Oct;34(32):7994-8001.
2013-07	Andrographis paniculata extract and andrographolide modulate the hepatic drug metabolism system and plasma tolbutamide concentrations in rats	Evidence-Based Complementary and Alternative Medicine. 2013 Jul;2013:Article number 982689.
2013-06-28	Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor	Journal of Medicinal Chemistry. 2013 Jun 28;56(13):5247-5260.
2013-06	Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2013 Jun;21(11):2856-2867.
2013-06	Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence	Journal of Microbiology. 2013 Jun;51(3):345-351.
2013-05	H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline in senescent human fetal mesenchymal stem cells	Antioxidants and Redox Signaling. 2013 May;18(15):1895-1905.
2013-05	Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	Proceedings of the National Academy of Sciences of the United States of America. 2013 May;110(19):E1779-E1787.
2013-01-23	In vivo imaging of brain infarct with the novel fluorescent probe psvue 794 in a rat middle cerebral artery occlusion-reperfusion model	Molecular Imaging. 2013 Jan 23;12(1):8-16.
2013-01	Effects of pH on molecular mechanisms of chitosan–integrin interactions and resulting tight-junction disruptions	Biomaterials. 2013 Jan;34(3):784-793.
2012-09	Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan	Biomaterials. 2012 Sep;33(26):6254-6263.
2012-09	Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors	European Journal of Medicinal Chemistry. 2012 Sep;55:32-38.
2012-09	Putative tumor metastasis-associated genes in human gastric cancer	International Journal of Oncology. 2012 Sep;41(3):1068-1084.
2012-09	HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy	Clinical Cancer Research. 2012 Sep;18(17):4691-4701.
2012-06-07	3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry Letters. 2012 Jun 7;22(14):4654-4659.
2012-04	Securin enhances the anti-cancer effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in human colorectal cancer cells	PLoS ONE. 2012 Apr;7(4):Article number e36006.
2012-03	R432 is a key residue for the multiple functions of Ndt80p in Candida albicans	Cellular and Molecular Life Sciences. 2012 Mar;69(6):1011-1023.
2012-02	Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents	Investigational New Drugs. 2012 Feb;30(1):164-175.
2012-02	Discovery of novel stem cell mobilizers that target the CXCR4 receptor	ChemMedChem. 2012 Feb;7(2):209-212.
2012-01	BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML	British Journal of Cancer. 2012 Jan;106(3):475-481.
2011-11	Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins	Biomaterials. 2011 Nov;32(33):8712-8721.
2011-10	Antiproliferative effects of N-heterocyclic indolyl glyoxylamide derivatives on human lung cancer cells	Anticancer Research. 2011 Oct;31(10):3407-3415.
2011-07	Immune response and pathophysiological features of Klebsiella pneumoniae liver abscesses in an animal model	Laboratory Investigation. 2011 Jul;91(7):1029-1039.

Showing items 76-100 of 157. (7 Page(s) Totally) << < 1 2 3 4 5 6 7 > >> View [10|25|50] records per page